FindTrial
Sign In

A comparison of the incidence of infective endocarditis and prosthetic valve dysfunctions after aortic valve replacement in One-way limiting expandable artificial biological heart valve and mechanical heart valve

A comparison of the incidence of infective endocarditis and prosthetic valve dysfunctions after aortic valve replacement in One-way limiting expandable artificial biological heart valve and mechanical heart valve

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097558
Enrollment
Unknown
Registered
2025-02-20
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart valve disease

Interventions

One-way limiting expandable artificial biological heart valve:None
mechanical heart valve:None

Sponsors

Shandong Provincial Hospital Affiliated to Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) over 55 years of age;(2) Surgical aortic valve artificial valve replacement;

Exclusion criteria

Exclusion criteria: (1) Patients with other cardiovascular diseases other than aortic valve disease requiring simultaneous surgery; (2) multiple organ dysfunction; (3) Patients with mental diseases who can not effectively cooperate with surgery; (4) Patients currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Evaluation of perivalvular leakage;Infective endocarditis;Biological structural valve failure (SVD);Bleeding from anticoagulants;Valve function failure condition;—

Secondary

MeasureTime frame
Tracheal intubation time;ICU stay time;hospitalization time;Valve-related resurgery;NYHA cardiac function classification;—

Countries

China

Contacts

Public ContactQingbao Li

Shandong provincial hospital Affiliated Shandong First Medical University

qingbao2004@sina.com+86 151 6888 6211

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026